Providing novel MRI-enhanced clinical informatics to transform cardiac care and standardize preventative cardiac population management #CardioOnc#CVD#HF#MRI
This COPD Month, Myocardial Solutions is committed to advancing cardiovascular health and early disease detection with our MyoStrain test. Together we can work to improve the heart and lung health of patients worldwide.
#COPDmonth#COPDAwareness
A recent study by UTSW reveals the hidden risks and causes of undetected hypertension. Discover how our cutting-edge MyoStrain technology could be the key to catching early damage and dysfunction.
Read the article here: https://t.co/Y2dra7uAnn
MyoStrain technology is a game-changer for cardiology. It empowers physicians to proactively identify patients who may benefit from early cardioprotective therapy. Hear from more physicians by visiting our website: https://t.co/SWOqsivjjR
For Breast Cancer Awareness Month, we want to call attention to a PREFECT Study that highlights MyoStrain & MyoHealth score’s potential impact on breast cancer care. Join us in advancing cancer patient care. Read here: https://t.co/qSx53p3fVb
Traditional heart metrics fall short in evaluating individual responses to heart failure medications. MyoStrain empowers physicians with sensitivity and precision, revolutionizing treatment optimization. Learn more here: https://t.co/Pz3Dv7kvJw
We would like to extend our thanks to our expert panelists for highlighting MyoStrain's impact in cardio-oncology at #GCOS2023. We look forward to continuing these important conversations in the future
This month, Dr. Daniel Lenihan highlighted MyoStrain's role in early cardiotoxicity detection at #GCOS2023. To read the PREFECT study from the panel, please visit the following page: https://t.co/qSx53p3fVb
Discover the groundbreaking potential of MyoStrain through the eyes of leading physicians. Hear how it's transforming cancer therapy monitoring and promoting cardio-protective strategies: https://t.co/SWOqsivjjR
According to @WHO’s latest report, 76 million lives could be saved by 2050 if we effectively manage hypertension.https://t.co/syTwG5Zgsn
Let's work together to empower our healthcare system to manage hypertension using MyoStrain tests.
Thrilled to have been part of the #GCOS2023 summit hosted by @ICOSociety! Myocardial Solutions was proud to sponsor and engage with thought leaders - sharing insights on how MyoStrain is revolutionizing cardiac care.
Congratulations to our incredible speakers who led a panel discussion at #GCOS2023 this weekend. Alexander Lyon, Susan Dent, Eliseo Vaño, and Daniel Lenihan led an engaging symposium on MyoStrain® and its impact on cardio-oncology care. We look forward to next year! @ICOSociety
Elevate your clinical practice with MyoStrain and enhance your patients’ cardiac health one scan at a time. Register for MyoStrain training here: https://t.co/CsoOmFYvMI
MyoStrain offers a game-changing solution with its rapid and accurate assessment. Learn more about how this technology is helping mitigate false negative and positive test results:
https://t.co/GbrYmECHy8
#MyoStrain enables physicians to detect heart dysfunction early and treat patients before heart damage occurs. The MyoHealth™ Score represents the percentage of a patient's heart that is functioning normally. #HeartMonth#Cardiology@American_Heart @TheHeartTruth